These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 16024615)
1. Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Udabage L; Brownlee GR; Waltham M; Blick T; Walker EC; Heldin P; Nilsson SK; Thompson EW; Brown TJ Cancer Res; 2005 Jul; 65(14):6139-50. PubMed ID: 16024615 [TBL] [Abstract][Full Text] [Related]
2. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Li Y; Li L; Brown TJ; Heldin P Int J Cancer; 2007 Jun; 120(12):2557-67. PubMed ID: 17315194 [TBL] [Abstract][Full Text] [Related]
3. Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes. Rilla K; Lammi MJ; Sironen R; Törrönen K; Luukkonen M; Hascall VC; Midura RJ; Hyttinen M; Pelkonen J; Tammi M; Tammi R J Cell Sci; 2002 Sep; 115(Pt 18):3633-43. PubMed ID: 12186949 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo. Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer. Li P; Xiang T; Li H; Li Q; Yang B; Huang J; Zhang X; Shi Y; Tan J; Ren G Int J Clin Exp Pathol; 2015; 8(10):12101-14. PubMed ID: 26722395 [TBL] [Abstract][Full Text] [Related]
6. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane. Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962 [TBL] [Abstract][Full Text] [Related]
7. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Udabage L; Brownlee GR; Nilsson SK; Brown TJ Exp Cell Res; 2005 Oct; 310(1):205-17. PubMed ID: 16125700 [TBL] [Abstract][Full Text] [Related]
8. HAS2 and CD44 in breast tumorigenesis. Heldin P; Basu K; Kozlova I; Porsch H Adv Cancer Res; 2014; 123():211-29. PubMed ID: 25081531 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Okuda H; Kobayashi A; Xia B; Watabe M; Pai SK; Hirota S; Xing F; Liu W; Pandey PR; Fukuda K; Modur V; Ghosh A; Wilber A; Watabe K Cancer Res; 2012 Jan; 72(2):537-47. PubMed ID: 22113945 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of hyaluronan synthases decreases matrix metalloproteinase-7 (MMP-7) expression and activity. Dunn KM; Lee PK; Wilson CM; Iida J; Wasiluk KR; Hugger M; McCarthy JB Surgery; 2009 Mar; 145(3):322-9. PubMed ID: 19231585 [TBL] [Abstract][Full Text] [Related]
11. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors. Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760 [TBL] [Abstract][Full Text] [Related]
12. Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer. Kolliopoulos C; Lin CY; Heldin CH; Moustakas A; Heldin P Matrix Biol; 2019 Jul; 80():29-45. PubMed ID: 30194979 [TBL] [Abstract][Full Text] [Related]
13. A novel role of low molecular weight hyaluronan in breast cancer metastasis. Wu M; Cao M; He Y; Liu Y; Yang C; Du Y; Wang W; Gao F FASEB J; 2015 Apr; 29(4):1290-8. PubMed ID: 25550464 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1). Bernert B; Porsch H; Heldin P J Biol Chem; 2011 Dec; 286(49):42349-42359. PubMed ID: 22016393 [TBL] [Abstract][Full Text] [Related]
16. Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation. Itano N; Sawai T; Atsumi F; Miyaishi O; Taniguchi S; Kannagi R; Hamaguchi M; Kimata K J Biol Chem; 2004 Apr; 279(18):18679-87. PubMed ID: 14724275 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance. Lien HC; Lee YH; Jeng YM; Lin CH; Lu YS; Yao YT Histopathology; 2014 Sep; 65(3):328-39. PubMed ID: 24527698 [TBL] [Abstract][Full Text] [Related]
18. The natural antisense transcript HAS2-AS1 regulates breast cancer cells aggressiveness independently from hyaluronan metabolism. Parnigoni A; Caon I; Teo WX; Hua SH; Moretto P; Bartolini B; Viola M; Karousou E; Yip GW; Götte M; Heldin P; Passi A; Vigetti D Matrix Biol; 2022 May; 109():140-161. PubMed ID: 35395387 [TBL] [Abstract][Full Text] [Related]
19. Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice. Simpson MA Am J Pathol; 2006 Jul; 169(1):247-57. PubMed ID: 16816377 [TBL] [Abstract][Full Text] [Related]
20. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Kultti A; Pasonen-Seppänen S; Jauhiainen M; Rilla KJ; Kärnä R; Pyöriä E; Tammi RH; Tammi MI Exp Cell Res; 2009 Jul; 315(11):1914-23. PubMed ID: 19285976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]